- Home
- CGON vs AMPL Comparison
CGON vs AMPL Comparison
Compare CGON & AMPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- AMPL
- Stock Information
- Founded
- CGON 2010
- AMPL 2012
- Country
- CGON United States
- AMPL United States
- Employees
- CGON N/A
- AMPL N/A
- Industry
- CGON
- AMPL EDP Services
- Sector
- CGON
- AMPL Technology
- Exchange
- CGON NYSE
- AMPL Nasdaq
- Market Cap
- CGON 1.3B
- AMPL 1.5B
- IPO Year
- CGON 2024
- AMPL 2021
- Fundamental
- Price
- CGON $24.13
- AMPL $10.50
- Analyst Decision
- CGON Strong Buy
- AMPL Buy
- Analyst Count
- CGON 11
- AMPL 10
- Target Price
- CGON $62.90
- AMPL $13.40
- AVG Volume (30 Days)
- CGON 2.0M
- AMPL 951.3K
- Earning Date
- CGON 05-16-2025
- AMPL 05-07-2025
- Dividend Yield
- CGON N/A
- AMPL N/A
- EPS Growth
- CGON N/A
- AMPL N/A
- EPS
- CGON N/A
- AMPL N/A
- Revenue
- CGON $1,139,000.00
- AMPL $306,601,000.00
- Revenue This Year
- CGON N/A
- AMPL $11.64
- Revenue Next Year
- CGON $16,237.24
- AMPL $10.90
- P/E Ratio
- CGON N/A
- AMPL N/A
- Revenue Growth
- CGON 461.08
- AMPL 8.56
- 52 Week Low
- CGON $14.80
- AMPL $7.37
- 52 Week High
- CGON $40.47
- AMPL $14.88
- Technical
- Relative Strength Index (RSI)
- CGON 51.00
- AMPL 63.48
- Support Level
- CGON $21.00
- AMPL $9.09
- Resistance Level
- CGON $30.23
- AMPL $9.64
- Average True Range (ATR)
- CGON 2.31
- AMPL 0.47
- MACD
- CGON 0.16
- AMPL 0.26
- Stochastic Oscillator
- CGON 34.09
- AMPL 87.28
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About AMPL Amplitude Inc.
Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.